» Articles » PMID: 12007998

Endothelium-dependent Hyperpolarization As a Remote Anti-atherogenic Mechanism

Overview
Specialty Pharmacology
Date 2002 May 15
PMID 12007998
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial cell injury and the loss of cytoprotective mechanisms that involve nitric oxide, prostacyclin and endothelium-dependent hyperpolarization (EDH) are thought to underlie atherosclerosis, although how these mechanisms are anti-atherogenic is unclear. This is particularly so because thrombus formation, one of the major initiators of the disease, usually occurs at discrete luminal sites; thus, only small numbers of endothelial cells can be recruited to initiate anti-inflammatory responses. However, we, and others, have demonstrated that locally generated EDH spreads to endothelial cells and smooth muscle cells throughout a vessel to cause remote vasodilatation. In this article, we propose that, in addition to a widespread inhibitory signalling mechanism, EDH produced by the endothelium also initiates remote anti-inflammatory actions that prevent large blood vessels developing atherosclerosis.

Citing Articles

Coronary plaque burden predicts perioperative cardiovascular events after coronary endarterectomy.

Gao M, Wen W, Gu C, Zhang X, Yu Y, Li H Front Cardiovasc Med. 2023; 10:1175287.

PMID: 37363096 PMC: 10289079. DOI: 10.3389/fcvm.2023.1175287.


Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease.

Ozkor M, Murrow J, Rahman A, Kavtaradze N, Lin J, Manatunga A Circulation. 2011; 123(20):2244-53.

PMID: 21555712 PMC: 3407597. DOI: 10.1161/CIRCULATIONAHA.110.990317.


Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?.

Feletou M Br J Pharmacol. 2009; 156(4):545-62.

PMID: 19187341 PMC: 2697708. DOI: 10.1111/j.1476-5381.2009.00052.x.


Definitive role for natriuretic peptide receptor-C in mediating the vasorelaxant activity of C-type natriuretic peptide and endothelium-derived hyperpolarising factor.

Villar I, Panayiotou C, Sheraz A, Madhani M, Scotland R, Nobles M Cardiovasc Res. 2007; 74(3):515-25.

PMID: 17391657 PMC: 3503309. DOI: 10.1016/j.cardiores.2007.02.032.


Back to the salt mines-- endothelial dysfunction in hypertension and compensatory role of endothelium-derived hyperpolarizing factor (EDHF).

Katusic Z J Physiol. 2002; 543(Pt 1):1.

PMID: 12181276 PMC: 2290466. DOI: 10.1113/jphysiol.2002.025478.